Antiverse

Antiverse is a new type of antibody discovery company accelerating drug development. The Antiverse platform exists at the intersection of structural biology, machine learning and medicine to enable breakthroughs to happen more quickly and cost effectively. Recognised as one of the top biotech startups in the UK, their service is already in use by big pharma. Founded in 2017 with pre-seed investment from Deep Science Ventures, Antiverse is dedicated to engineering the future of drug development to change the course of people's lives. The company is headquartered in Cardiff, Wales.